These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15834858)

  • 1. Atypical Hallervorden-Spatz disease with preserved cognition and obtrusive obsessions and compulsions.
    Nicholas AP; Earnst KS; Marson DC
    Mov Disord; 2005 Jul; 20(7):880-6. PubMed ID: 15834858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.
    Sethi KD; Adams RJ; Loring DW; el Gammal T
    Ann Neurol; 1988 Nov; 24(5):692-4. PubMed ID: 3202617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis.
    Vasconcelos OM; Harter DH; Duffy C; McDonough B; Seidman JG; Seidman CE; Campbell WW
    Muscle Nerve; 2003 Jul; 28(1):118-22. PubMed ID: 12811783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of Hallervorden-Spatz disease with magnetic resonance imaging data].
    Ruiz-Sandoval JL; García-Ramos G; Vega-Boada F; Estañol-Vidal B
    Rev Invest Clin; 1998; 50(3):249-53. PubMed ID: 9763892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult onset Hallervorden-Spatz disease with psychotic symptoms.
    del Valle-López P; Pérez-García R; Sanguino-Andrés R; González-Pablos E
    Actas Esp Psiquiatr; 2011; 39(4):260-2. PubMed ID: 21769749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)].
    Carod-Artal FJ; Vargas AP; Marinho PB; Fernandes-Silva TV; Portugal D
    Rev Neurol; 2004 Feb 16-29; 38(4):327-31. PubMed ID: 14997456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallervorden-Spatz syndrome in two siblings diagnosed by clinical features and magnetic resonance imaging.
    Tiamkao S; Nitinavakarn B; Jitpimolmard S
    J Med Assoc Thai; 2000 Dec; 83(12):1535-40. PubMed ID: 11253896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic atrophy as the presenting sign in Hallervorden-Spatz syndrome.
    Casteels I; Spileers W; Swinnen T; Demaerel P; Silberstein J; Casaer P; Missotten L
    Neuropediatrics; 1994 Oct; 25(5):265-7. PubMed ID: 7885538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
    Hayflick SJ; Westaway SK; Levinson B; Zhou B; Johnson MA; Ching KH; Gitschier J
    N Engl J Med; 2003 Jan; 348(1):33-40. PubMed ID: 12510040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure akinesia: an unusual phenotype of Hallervorden-Spatz syndrome.
    Molinuevo JL; Martí MJ; Blesa R; Tolosa E
    Mov Disord; 2003 Nov; 18(11):1351-3. PubMed ID: 14639680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene.
    Zumrová A; Krepelová A; Kyncl M; Maríková T; Prosková M; Cíbochová R; Sebronová V; Komárek V
    Neuro Endocrinol Lett; 2005 Jun; 26(3):213-8. PubMed ID: 15990724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance tomography confirms the diagnosis of Hallervorden-Spatz disease].
    Scheer PJ; Perz A; Ebner F; Kratky-Dunitz M
    Padiatr Padol; 1988; 23(3):245-52. PubMed ID: 3186269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallervorden spatz disease: MR and pathological findings of a rare case.
    Sharma MC; Aggarwal N; Bihari M; Goyal V; Gaikwed S; Vaishya S; Sarkar C
    Neurol India; 2005 Mar; 53(1):102-4. PubMed ID: 15805666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hallervorden-Spatz disease: presentation of a new case].
    Pedrola D; Pineda M; Fernández Alvarez E
    Rev Neurol; 1995; 23(119):51-3. PubMed ID: 8548643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of nuclear magnetic imaging in the diagnosis of Hallervorden-Spatz syndrome].
    Pedespan JM; Fontan D; Castell JF; Langlade P; Guillard JM
    Arch Fr Pediatr; 1993 Jan; 50(1):35-7. PubMed ID: 8507137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome).
    Kapoor S; Hortnagel K; Gogia S; Paul R; Malhotra V; Prakash A
    Indian J Pediatr; 2005 Mar; 72(3):261-3. PubMed ID: 15812126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum of Hallervorden-Spatz syndrome in India.
    Sachin S; Goyal V; Singh S; Shukla G; Sharma MC; Gaikwed S; Behari M
    J Clin Neurosci; 2009 Feb; 16(2):253-8. PubMed ID: 19056277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallerborden Spatz disease.
    Raji V; Dhanasegaran SE; Usha ; Subramanian K; Suresh ; Kumar S
    J Assoc Physicians India; 2006 Apr; 54():320-2. PubMed ID: 16944616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.